E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/16/2012 in the Prospect News Distressed Debt Daily.

Quigley net loss shrinks to $307,826 in March on $50,000 revenues

By Lisa Kerner

Charlotte, N.C., April 16 - Quigley Co. Inc. reported a $307,826 net loss for March on $50,000 of revenues, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the Southern District of New York.

In comparison, Quigley posted a $514,888 net loss for February, also on $50,000 of revenues.

Cash and cash equivalents were $88,986 at March 31, up from $78,858 at the end of February.

Quigley, a unit of New York-based Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.